chr11-108365552-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000051.4(ATM):​c.*44A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00163 in 1,590,728 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0059 ( 9 hom., cov: 31)
Exomes 𝑓: 0.0012 ( 7 hom. )

Consequence

ATM
NM_000051.4 3_prime_UTR

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.0930

Publications

4 publications found
Variant links:
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]
C11orf65 (HGNC:28519): (chromosome 11 open reading frame 65) Predicted to be involved in negative regulation of mitochondrial fission and negative regulation of protein targeting to mitochondrion. Predicted to be located in cytosol and mitochondrial outer membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 11-108365552-A-G is Benign according to our data. Variant chr11-108365552-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 302256.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00586 (893/152286) while in subpopulation AFR AF = 0.0174 (725/41558). AF 95% confidence interval is 0.0164. There are 9 homozygotes in GnomAd4. There are 409 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 9 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
NM_000051.4
MANE Select
c.*44A>G
3_prime_UTR
Exon 63 of 63NP_000042.3
ATM
NM_001351834.2
c.*44A>G
3_prime_UTR
Exon 64 of 64NP_001338763.1
C11orf65
NM_001330368.2
c.640+20368T>C
intron
N/ANP_001317297.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
ENST00000675843.1
MANE Select
c.*44A>G
3_prime_UTR
Exon 63 of 63ENSP00000501606.1
ATM
ENST00000452508.7
TSL:1
c.*44A>G
3_prime_UTR
Exon 64 of 64ENSP00000388058.2
C11orf65
ENST00000615746.4
TSL:1
c.*2-9443T>C
intron
N/AENSP00000483537.1

Frequencies

GnomAD3 genomes
AF:
0.00588
AC:
894
AN:
152168
Hom.:
9
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0175
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00504
Gnomad ASJ
AF:
0.0133
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000829
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000426
Gnomad OTH
AF:
0.00574
GnomAD2 exomes
AF:
0.00247
AC:
536
AN:
217182
AF XY:
0.00195
show subpopulations
Gnomad AFR exome
AF:
0.0180
Gnomad AMR exome
AF:
0.00177
Gnomad ASJ exome
AF:
0.0147
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000633
Gnomad OTH exome
AF:
0.00217
GnomAD4 exome
AF:
0.00118
AC:
1698
AN:
1438442
Hom.:
7
Cov.:
29
AF XY:
0.00112
AC XY:
801
AN XY:
714374
show subpopulations
African (AFR)
AF:
0.0182
AC:
596
AN:
32784
American (AMR)
AF:
0.00219
AC:
91
AN:
41536
Ashkenazi Jewish (ASJ)
AF:
0.0142
AC:
366
AN:
25772
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38934
South Asian (SAS)
AF:
0.00117
AC:
98
AN:
84010
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52468
Middle Eastern (MID)
AF:
0.00175
AC:
10
AN:
5722
European-Non Finnish (NFE)
AF:
0.000360
AC:
395
AN:
1097576
Other (OTH)
AF:
0.00238
AC:
142
AN:
59640
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
94
188
282
376
470
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00586
AC:
893
AN:
152286
Hom.:
9
Cov.:
31
AF XY:
0.00549
AC XY:
409
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.0174
AC:
725
AN:
41558
American (AMR)
AF:
0.00504
AC:
77
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0133
AC:
46
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4822
European-Finnish (FIN)
AF:
0.0000943
AC:
1
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000426
AC:
29
AN:
68028
Other (OTH)
AF:
0.00568
AC:
12
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
43
85
128
170
213
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00263
Hom.:
1
Bravo
AF:
0.00714
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
Ataxia-telangiectasia syndrome (1)
-
-
1
Hereditary breast ovarian cancer syndrome (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
1.7
DANN
Benign
0.42
PhyloP100
-0.093
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55900855; hg19: chr11-108236279; API